Exploring the continuum: Medical information to effective clinical practice*. Paper II. Towards aetiology-centred clinical practice

Journal of Evaluation in Clinical Practice

Volumn 12, Issue 1, 2006, Pages 63-75

  Genuis, Stephen J ^a,b   Genuis, Shelagh K ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b University of Alberta ^*  (Canada)

Author keywords

Clinical practice; Doctor's role; Epidemiology; Evidence based medicine; Health policy; Health promotion; Medical education; Medical research; Preventive medicine; Professional ethics

Indexed keywords

CAUSAL ATTRIBUTION; CHRONIC DISEASE; CLINICAL PRACTICE; DISEASE MANAGEMENT; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL RESEARCH; PATIENT CARE; PHYSICIAN ATTITUDE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW;

CHRONIC DISEASE; DIFFUSION OF INNOVATION; DISEASE; HEALTH PROMOTION; HUMANS; PATIENT-CENTERED CARE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 32344444840     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2005.00609.x     Document Type: Review

References (117)

1. Angell M. (2000) Is academic medicine for sale? New England Journal of Medicine 342, 1516-1518.
2. Bahrke U., Arends M., Bandemer-Greulich U., Dreyer B., Ropke H. & Fikentscher E. (2003) The incidence of pathological eating behaviour among schoolchildren in a large urban area. Psychotherapy, Psychosomatic Medicine and Psychology 53, 29-34.
3. Baynes K.C., Boucher B.J., Feskens E.J. & Kromhout D. (1997) Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40, 344-347.
4. Berkson D.L. (2000) Hormone Deception. Contemporary Publishing Group, Chicago.
5. Bettica P., Bevilacqua M., Vago T. & Norbiato G. (1999) High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis out-patient clinic in northern Italy for initial screening. Osteoporosis International 9, 226-229.
6. Bigsby R., Chapin R.E., Daston G.P., Davis B.J., Gorski J., Gray L.E., Howdeshell K.L., Zoeller R.T. & vom Saal F.S. (1999) Evaluating the effects of endocrine disrupters on endocrine function during development. Environmental Health Perspectives 107 (Suppl. 4), 613-618.
7. Borsellino M. (2003a) Further bureaucratic monitoring in store? Medical Post 39, 4.
8. Borsellino M. (2003b) MDs successful fight against MRC paves way for more. Medical Post 39 (2), 73.
9. Bourlon P.M., Billaudel B. & Faure-Dussert A. (1999) Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. Journal of Endocrinology 160, 87-95.
10. Callahan D. (1999) Remembering the goals of medicine. Journal of Evaluation in Clinical Practice 5, 103-106.
11. Canadian Medical Association. (2003) Who cares for the caregiver? Canadian Medical Association Interface 4, 2.
12. Cauley J.A., Robbins J., Chen Z. et al (2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. Journal of the American Medical Association 290, 1729-1738.
13. Cohn D. (2002) Disability rate of children, teens up sharply - to 1 in 12. Washington Post, 6 July.
14. Colborn T., vom Saal F.S. & Soto A.M. (1993) Developmental effects of endocrine-disrupting chemicals in wild-life and humans. Environmental Health Perspectives 101, 378-384.
15. Cole P. (1979) The evolving case-control study. Journal of Chronic Disease 32, 15-27.
16. Cordain L., Eades M.R. & Eades M.D. (2003) Hyperinsulinemic diseases of civilization: more than just Syndrome X. Comparative Biochemistry and Physiology. Part A, Molecular and Integrative Physiology 136, 95-112.
17. Davis R.M., Wagner E.H. & Groves T. (1999) Managing chronic disease. British Medical Journal 318, 1090-1091.
18. Davis R.M., Wagner E.G. & Groves T. (2000) Advances in managing chronic disease. Research, performance measurement, and quality improvement are key. British Medical Journal 320, 525-526.
19. Din J.N., Newby D.E. & Flapan A.D. (2004) Omega 3 fatty acids and cardiovascular disease - fishing for a natural treatment. British Medical Journal 328, 30-35.
20. Ebbesen J., Buajordet I., Erikssen J., Brors O., Hilberg T., Svaar H. & Sandvik L. (2001) Drug-related deaths in a department of internal medicine. Archives of International Medicine 161, 2317-2323.
21. Ebrahim S. & Lau E. (2001) Commentary: sick populations and sick individuals. International Journal of Epidemiology 30, 433-434.
22. Etzel R.A. & Balk S.J. (1999) American Academy of Pediatrics, Committee on Environmental Health. Handbook of Pediatric Environmental Health. American Academy of Pediatrics, Elk Grove Village, IL.
23. Feskanich D., Willett W.C. & Colditz G.A. (2003) Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. American Journal of Clinical Nutrition 77, 504-511.
24. Frank A.L. (2000) Approach to the patient with an occupational or environmental illness. Primary Care 27, 877-894.
25. Garland C.F., Garland F.C. & Gorham E.D. (1999) Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Annals of the New York Academy of Sciences 889, 107-119.
26. Geier M.R. & Geier D.A. (2003) Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the United States. Journal of the American Physicians and Surgeons 8, 6-11.
27. Genuis S.J. (2005) Nutritional transition: a determinant of global health. Journal of Epidemiology and Community Health (in press).
28. Genuis S.J. & Genuis S.K. (2004) Human exposure assessment and relief from neuropsychiatric symptoms. Journal of the American Board of Family Practice 17, 136-141.
29. Genuis S.K. & Genuis S.J. (2005) Exploring the continuum: medical information to effective clinical practice. Paper 1. Evaluating the translation of knowledge into practice. Journal of Evaluation in Clinical Practice doi:10.1111/j.1365-2753.2005.00608.x.
30. Gidwani P.P., Sobol A., DeJong W., Perrin J.M. & Gortmaker S.L. (2002) Television viewing and initiation of smoking among youth. Pediatrics 110, 505-508.
31. Haag M. (2003) Essential fatty acids and the brain. Canadian Journal of Psychiatry 48, 195-203.
32. Higgins G. (2004) We are not respected for our real value. Alberta Doctors' Digest 29, 2-4.
33. Holick M.F. (2003) The UV Advantage. Prima Publishing, Rocklin, CA.
34. Holick M.F. (2004a) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition 79, 362-371.
35. Holick M.F. (2004b) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. American Journal of Clinical Nutrition 80, 1678S-1688S.
36. Horton R. (2002) The doctor's role in advocacy. Lancet 359, 458.
37. Hu F.B., Manson J.E. & Willett W.C. (2001) Types of dietary fat and risk of coronary heart disease: a critical review. Journal of the American College of Nutrition 20, 5-19.
38. Hu F.B., Stampfer M.J., Manson J.E., Rimm E.B., Colditz G.A., Rosner B.A., Speizer F.E., Hennekens C.H. & Willett W.C. (1998) Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. British Medical Journal 317, 1341-1345.
39. Jacques P.F., Hartz S.C., Chylack L.T. Jr, McGandy R.B. & Sadowski J.A. (1988) Nutritional status in persons with and without senile cataract: blood vitamin and mineral levels. American Journal of Clinical Nutrition 48, 152-158.
40. Jesudason D., Need A.G., Horowitz M., O'Loughlin P.D., Morris H.A. & Nordin B.E. (2002) Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 31, 626-630.
41. John E.M., Schwartz G.G., Dreon D.M. & Koo J. (1999) Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiology Biomarkers and Prevention 8, 399-406.
42. Johnson J., Cohen P., Smailes E., Kasen S. & Brook J. (2002) Television viewing and aggressive behavior during adolescence and adulthood. Science 295, 2468-2471.
43. Jolly E., Hauck B., Mailloux J., Robichaud A., Rowe T., Sabbah R. & Wolfman W. (2004) Hormone therapy for post-menopausal women in the new millenium. Expert Discussion Forum: Linking Evidence-Based Medicine to Clinical Practice 3, 1-8.
44. Kavlock R.J. (1999) Overview of endocrine disruptor research activity in the United States. Chemosphere 39, 1227-1236.
45. Khattak S., Moghtader G.K., McMartin K., Barrera M., Kennedy D. & Koren G. (1999) Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study. Journal of the American Medical Association 281, 1106-1109.
46. Kilpatrick N., Frumkin H., Trowbridge J., Escoffery C., Geller R., Rubin L., Teague G. & Nodvin J. (2002) The environmental history in pediatric practice: a study of pediatricians' attitudes, beliefs, and practices. Environmental Health Perspectives 110, 823-827.
47. Kleibeuker J.H., van der Meer R. & de Vries E.G. (1995) Calcium and vitamin D: possible protective agents against colorectal cancer? European Journal of Cancer 31A, 1081-1084.
48. Knox E.G. (2005) Childhood cancers and atmospheric carcinogens. Journal of Epidemiology and Community Health 59, 101-105.
49. Kondro W. (2002) Threats to medical professionalism tackled in Canada. Lancet 360, 316.
50. Kopelman P. & Lennard-Jones J. (2002) Nutrition and patients: a doctor's responsibility. Clinical Medicine 2, 391-394.
51. Lambert G.W., Reid C., Kaye D.M., Jennings G.L. & Esler M.D. (2002) Effect of sunlight and season on serotonin turnover in the brain. Lancet 360, 1840-1842.
52. Lazarou J., Pomeranz B.H. & Corey P.N. (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Journal of the American Medical Association. 279, 1200-1205.
53. Lefkowitz E.S. & Garland C.F. (1994) Sunlight, vitamin D, and ovarian cancer mortality rates in US women. International Journal of Epidemiology 23, 1133-1136.
54. Lehtonen-Veromaa M.K., Mottonen T.T., Nuotio I.O., Irjala K.M., Leino A.E. & Viikari J.S. (2002) Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study. American Journal of Clinical Nutrition 76, 1446-1453.
55. Liberati A. & Magrini N. (2003) Information from drug companies and opinion leaders. British Medical Journal 326, 1156-1157.
56. Linday L., Dolitsky J., Shindledecker R. & Pippenger J. (2002) Lemon-flavored cod liver oil and a multivitamin-mineral supplement for the secondary prevention of otitis media in young children: pilot research. Annals of Otology, Rhinology, Laryngology 111, 642-652.
57. Lipman T. (2000) Power and influence in clinical effectiveness and evidence-based medicine. Family Practice 17, 557-563.
58. Mandal V. (2003) Audited to death? MD Canada 1, 13-21.
59. Marshall L.M. (2002) Exposure history. In The Ontario College of Family Physicians [association website][cited 30 August 2003]. Available at: http://www.ocfp.on.ca/local/files/EHC/Exposure%20Hx%20Forms.pdf
60. Marshall L., Weir E., Abelsohn A. & Sanborn M.D. (2002) Identifying and managing adverse environmental health effects: 1. Taking an exposure history. Canadian Medical Association Journal 166, 1049-1055.
61. McCormick J. (2001) Commentary: reflections on sick individuals and sick populations. International Journal of Epidemiology 30, 434-435.
62. McGavock H. (2004) Prescription-related illness - a scandalous pandemic. Journal of Evaluation in Clinical Practice 10, 491-497.
63. Medical Professionalism Project (2002) Medical professionalism in the new millenium: a physicians' charter. Lancet 359, 520-522.
64. Merritt E.F. (1999) Human health and the environment: are physician educators lagging behind? Journal of the American Medical Association 281, 1661.
65. Meunier P.J., Roux C., Seeman E. et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. New England Journal of Medicine 350, 459-468.
66. Michaud C.M., Murray C.J. & Bloom B.R. (2001) Burden of Disease - Implications for future research. Journal of the American Medical Association 285, 535-539.
67. Michelson J. (2004) Critique of (im) pure reason: evidence-based medicine and common sense. Journal of Evaluation in Clinical Practice 10, 157-161.
68. Mihalynuk T.V., Scott C.S. & Coombs J.B. (2003) Self-reported nutrition proficiency is positively correlated with the perceived quality of nutrition training of family physicians in Washington State. American Journal of Clinical Nutrition 77, 1330-1336.
69. Miller G.J. (1998-99) Vitamin D and prostate cancer: biologic interactions and clinical potentials. Cancer Metastasis Reviews 17, 353-360.
70. Mintzes B., Barer M.L., Kravitz R.L., Bassett K., Lexchin J., Kazanjian A., Evans R.G., Pan R. & Marion S.A. (2003) How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Canadian Medical Association Journal 169, 405-412.
71. Misch D.A. (2002) Evaluating physicians' professionalism and humanism: the case for humanism 'connoisseurs'. Academic Medicine 77, 489-495.
72. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S. & Koplan J.P. (2001) The continuing epidemics of obesity and diabetes in the United States. Journal of the American Medical Association 286, 1195-1200.
73. Moynihan R. (2003) Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: disentanglement. British Medical Journal 326, 1193-1196.
74. Murray C.J.L. & Lopez A.D. (eds) (1996) The global burden of disease. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard University Press, Boston, MA.
75. National Women's Health Network. (2002) The Truth About Hormone Replacement Therapy. Prima Publishing, Roseville, CA.
76. Nettleton S. (1995) The Sociology of Health and Illness. Polity Press, Cambridge.
77. Nikiforuk G. & Fraser D. (1981) The etiology of enamel hypoplasia: a unifying concept. Journal of Pediatrics 98, 888-893.
78. Ott W.R. (1995) Human exposure assessment: the birth of a new science. Journal of Exposure Analysis and Environmental Epidemiology 5, 449-472.
79. Pellegrino E.D. (1993) The metamorphosis of medical ethics. A 30-year retrospective. Journal of the American Medical Association 269, 1158-1162.
80. Perera F.P. (1997) Environment and cancer: who are susceptible? Science 278, 1068-1073.
81. Pinker S. (2002) Doctor shortage in Quebec a real numbers game. Canadian Medical Association Journal 167, 288.
82. Pisani P., Bray F. & Parkin D.M. (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. International Journal of Cancer 97, 72-81.
83. Pooley J. (1999) Hamburger helper for newscasters. In Brill's Content, p. 46.
84. Pope A.M. & Rall D.P. (eds) (1995) Environmental Medicine: Integrating a Missing Element Into Medical Education. National Academy Press, Washington, DC.
85. Porta M. (2004) Is there life after evidence-based medicine? Journal of Evaluation in Clinical Practice 10, 147-152.
86. Rapp D.J. (2004) Our Toxic World: A Wake Up Call. Environmental Medical Research Foundation, Buffalo.
87. Reddy K.S. (2002) Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutrition 5, 231-237.
88. Relman A.S. & Angell M. (2002) America's other drug problem: how the drug industry distorts medicine and politics. New Republic 587, 27-41.
89. Robinson T.N. (1998) Does television cause childhood obesity. Journal of the American Medical Association 279, 959-960.
90. Rogan W.J. & Ragan N.B. (2003) Evidence of effects of environmental chemicals on the endocrine system in children. Pediatrics 112, 247-252.
91. Rogers S.A. (1994) The Scientific Basis for Selected Environmental Medicine Techniques. SK Publishing, Sarasota.
92. Rose G. (1985) Sick individuals and sick populations. International Journal of Epidemiology 14, 32-38.
93. Rosenthal M.B., Epstein A.M., Berndt E.R., Donohue J.M. & Frank R.G. (2003) Impact of Direct-to-Consumer Advertising on Prescription Drug Spending. The Henry J. Kaiser Family Foundation Report.
94. Sackett D.L., Richardson W.S., Rosenberg W. & Haynes R.B. (1997) Evidence-Based Medicine: How to Practice and Teach EBM. Churchill Livingstone, New York.
95. Saldeen P. & Saldeen T. (2004) Women and omega-3 Fatty acids. Obstetrical and Gynecological Survey 59, 722-730.
96. Sato Y., Asoh T. & Oizumi K. (1998) High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone 23, 555-557.
97. Sato Y., Kikuyama M. & Oizumi K. (1997) High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 49, 1273-1278.
98. Schwartz S. & Diez-Roux R. (2001) Commentary: causes of incidence and cause of cases - a Durkheimian perspective on Rose. International Journal of Epidemiolology 30, 435-439.
99. Snyder S.A., Westerhoff P., Yoon Y. & Sedlak D.L. (2003) Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environmental Engineering Science 20, 449-469.
100. Solomon G.M. & Schettler T. (2000) Environment and health: 6. Endocrine disruption and potential human health implications. Canadian Medical Association Journal 163, 1471-1476.
101. Stevens L.J., Zentall S.S., Abate M.L., Kuczek T. & Burgess J.R. (1996) Omega-3 fatty acids in boys with behavior, learning and health problems. Physiology and Behavior 59, 915-920.
102. Stevens L.J., Zentall S.S., Deck J.L., Abate M.L., Watkins B.A., Lipp S.R. & Burgess J.R. (1995) Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. American Journal of Clinical Nutrition 62, 761-768.
103. Trivedi D.P., Doll R. & Khaw K.T. (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. British Medical Journal 326, 469.
104. Uberos D.J., Gomez A., Munoz A., Molina A., Galdo G. & Perez F.J. (1998) Television and childhood injuries: is there a connection? Archives of Pediatric and Adolescent Medicine 152, 712-714.
105. United States Public Health Service. Office of the Surgeon General (1988) The Surgeon General's Report on Nutrition and Health. Public Health and Disease Prevention. DHHS (PHS) Publication 88-50210.1-750.
106. Upton M.N., McConnachie A., McSharry C., Hart C.L., Smith G.D., Gillis C.R. & Watt G.C. (2000) Intergenerational 20 year trends in the prevalence of asthma and hay fever: the Midspan family study survey of parents and offspring. British Medical Journal 321, 88-92.
107. Venitt S. (1994) Mechanisms of carcinogenesis and individual susceptibility to cancer. Clinical Chemistry 40, 1421-1425.
108. Villani S. (2001) Impact of media on children and adolescents: a 10-year review of the research. Journal of the American Academy of Child and Adolescent Psychiatry 40, 392-401.
109. Wagner E.H. & Groves T. (2002) Care for chronic diseases. British Medical Journal 325, 913-914.
110. Weir E. (2002) Identifying and managing adverse environmental health effects: a new series. Canadian Medical Association Journal 166, 1041-1043.
111. Whelton P.K., He J. & Muntner P. (2004) Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. Journal of Human Hypertension 18, 545-551.
112. Woolf S.H. & Johnson R.E. (2000) A one-year audit of topics and domains in the Journal of the American Medical Association and the New England Journal of Medicine. American Journal of Preventive Medicine 19, 79-86.
113. World Health Assembly. (2004) Global Strategy on Diet, Physical Activity and Health. WHA57.17. World Health Organization. Geneva, 1-20.
114. World Health Organization. (2002a) The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva.
115. World Health Organization. (2002b) World Report On Violence and Health. Geneva.
116. World Health Organization. Stewart B.W. & Kleihues P. (eds) (2003) World Cancer Report. International Agency for Research on Cancer.
117. Zittermann A., Schleithoff S.S., Tenderich G., Berthold H.K., Korfer R. & Stehle P. (2003) Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the American College of Cardiology 41, 105-112.